Foreigners remain net sellers of Japan stocks for 10th week [Reuters]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Reuters
Foreigners remain net sellers of Japan stocks for 10th week April 23 (Reuters) - Foreigners sold Japanese equities during the week ended April 17, marking their tenth straight week of net selling, as economic damage from COVID-19 weighed on investor sentiment. Overseas investors sold a net 434.56 billion yen ($4.03 billion) worth of local stocks last week, according to data from Japanese stock exchanges. They sold 301.98 billion yen in cash markets and 132.58 billion yen worth of derivatives last week. A slew of dire economic data released last week, crushed investors’ hopes that the world economy would be back on its feet any time soon. While a record 22 million Americans sought unemployment benefits over the past month, U.S. retail sales in March also plunged 8.7%. Output at U.S. factories also declined by the most since 1946. Local shares however, tracked gains in U.S. stocks last week, which surged after U.S. President Donald Trump unveiled a three-phase plan to gradually reopen t
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Royal Bank Of Canada from $100.00 to $103.00. They now have a "sector perform" rating on the stock.MarketBeat
- Gilead Sciences Earnings Preview: What to Expect [Yahoo! Finance]Yahoo! Finance
- Cell and Gene Therapy Investment Trends Strategic Intelligence Report 2025-2031: Yescarta from Gilead Sciences and Zolgensma from Novartis Generated $1.5 Billion and $1.2 Billion in 2024 Sales [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences (NASDAQ:GILD) had its price target lowered by analysts at Royal Bank Of Canada from $105.00 to $100.00. They now have a "sector perform" rating on the stock.MarketBeat
- Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $110.00 to $115.00. They now have a "neutral" rating on the stock.MarketBeat
GILD
Earnings
- 10/30/25 - Beat
GILD
Sec Filings
- 1/20/26 - Form 144
- 1/16/26 - Form 4
- 1/16/26 - Form 4
- GILD's page on the SEC website